[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351410-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-351410-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","role-of-sftpdmir-335-5plnc-hnrnpul2-axis-in-colorectal-cancer-in-silico-characterization-and-clinical-validation","Role of SFTPD/miR-335-5p/lnc-HNRNPUL2 axis in colorectal cancer - in silico characterization and clinical validation","","lnc-RNA, miRNA, and mRNA networks are widely studied for cancer regulation, and ceRNA network analysis supports discovery of diagnostic biomarkers. This research proposes and bioinformatically derives a serum Surfactant protein D (SFTPD)/miR-335-5p/lnc-HNRNPUL2 axis for colorectal cancer, then validates it using a pilot human cohort comparing CRC, control, and in vitro assays. Expression trends and functional effects assess its contribution to CRC pathogenesis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/role-of-sftpdmir-335-5plnc-hnrnpul2-axis-in-colorectal-cancer-in-silico-characterization-and-clinical-validation/351410/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/role-of-sftpdmir-335-5plnc-hnrnpul2-axis-in-colorectal-cancer-in-silico-characterization-and-clinical-validation/351410.png","ImageObject",300,407,{"name":42,"@type":43},"Alex Sinclair","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What axis is investigated for colorectal cancer?","Question",{"text":63,"@type":64},"The study focuses on the serum SFTPD/miR-335-5p/lnc-HNRNPUL2 axis, proposed via bioinformatics and evaluated in CRC versus control samples and CRC cell line HT29.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the proposed axis validated experimentally?",{"text":68,"@type":64},"Real-time PCR and ELISA were used to measure expression in serum from CRC patients, patients with benign tumors, and healthy controls, with additional confirmation in HT29 cells.",{"name":70,"@type":61,"acceptedAnswer":71},"What diagnostic performance did lnc-HNRNPUL2 and miR-335-5p show?",{"text":72,"@type":64},"lnc-HNRNPUL2 and hsa-miR-335-5p had significant predictive values for CRC diagnosis, with AUC values of 0.901 and 0.877, respectively.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},351410,1790170096,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":117,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":104,"preview_page_count":33,"preview_urls":144},1099523882182,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Matboli etal. BMC Cancer (2026) 26:459 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-15833-6](https://doi.org/10.1186/s12885-026-15833-6)  \nRESEARCH Open Access  \nRole ofSFTPD/miR-335-5p/lnc-HNRNPUL2 axis in colorectal cancer: in silico characterization and clinical validation  \nMarwa Matboli1,2*, Aly Elanwar3, Walaa Ibrahim4, Mohamed Kamel Hassan5, Marwa Ali1, Radwa Khaled2, Shady Montaser6, Sara Keshk6, Hadeel Medhat6, Marwa M Shafei7, Reham Atef Mohamed8,9 and  \nManar Ahmed Fouad 1  \nAbstract  \nBackground The lnc-RNA, miRNA, and mRNA networks have been extensively studied for cancer regulation. Furthermore, ceRNA network analysis has proved as an effective candidate for identifying potential diagnostic biomarkers in a variety of cancers. In this study, we described a novel axis of serum Surfactant protein D (SFTPD)/ miR-335-5p/lnc-HNRNPUL2 proposed by bioinformatics analysis and validated in a pilot human study of CRC versus control & in vitro assay to explore its role in the CRC pathogenesis.  \nMethods Real-time PCR and ELISA were used to validate the expression of this axis panel in serum samples from 81 CRC patients, 41 patients with benign tumors, and 30 healthy controls. Its expression was also confirmed in the CRC cell line HT29 .  \nResults Lnc-HNRNPUL2 and TGF-β expression levels were significantly upregulted in the sera of CRC patients compared to controls, along with a concurrent decrease in the expression of miR-335-5p and SFTPD mRNA in the CRC group relative to both benign and healthy control groups Interestingly, lnc-HNRNPUL2 and hsa-miR-335-5p had significant predictive values for CRC diagnosis due to their high sensitivities and specificities (AUC = 0.901 and 0. 877, respectively) . In addition, we silenced lnc-HNRNPUL2 in HT29 cells, which resulted in a significant decrease in cell count and viability, as well as a restoration of normal panel expression.  \nConclusion Together, these findings point to an oncogenic role for lnc-HNRNPUL2 in CRC, which acts via miR-335-5p suppression, followed by a decrease in SFTPD mRNA that is involved in immune surveillance against several cancers. The SFTPD/miR-335-5p/lnc-HNRNPUL2 axis shows high diagnostic accuracy for CRC detection. Low miR-335-5p expression was significantly associated with metastasis in Cox regression analysis, but longer follow-up is needed to establish prognostic value.  \nKeywords Colorectal cancer, Bioinformatics, Diagnosis, SiRNA, MiRNA, lncRNA  \n*Correspondence:  \nMarwa Matboli[marwasayed472@yahoo.com](marwasayed472@yahoo.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/licenses/by/4.0/.)  \nMatboli et al. BMC Cancer (2026) 26:459  \nIntroduction  \nColorectal cancer (CRC) is the third most common and the second most fatal cancer worldwide [1], with about 900,000 deaths estimated in 2020 [2]. The global incidence of CRC is predicted to be 2.5 million cases in 2035 [3]. In Egypt, the incidence of CRC is 5.1% in males and 4.7% in females, with a high rate of early CRC–35% of 1,600 Egyptian ","cbCaihhDLbY6IC6a","https://ap.wps.com/l/cbCaihhDLbY6IC6a","pdf",2927092,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Clinical burden and unmet need\n## Immune surveillance and biomarkers\n## Biological rationale for SFTPD","[{\"question\":\"What axis is investigated for colorectal cancer?\",\"answer\":\"The study focuses on the serum SFTPD/miR-335-5p/lnc-HNRNPUL2 axis, proposed via bioinformatics and evaluated in CRC versus control samples and CRC cell line HT29.\"},{\"question\":\"How was the proposed axis validated experimentally?\",\"answer\":\"Real-time PCR and ELISA were used to measure expression in serum from CRC patients, patients with benign tumors, and healthy controls, with additional confirmation in HT29 cells.\"},{\"question\":\"What diagnostic performance did lnc-HNRNPUL2 and miR-335-5p show?\",\"answer\":\"lnc-HNRNPUL2 and hsa-miR-335-5p had significant predictive values for CRC diagnosis, with AUC values of 0.901 and 0.877, respectively.\"}]","Role of SFTPD/miR-335-5p/lnc-HNRNPUL2 axis in colorectal cancer - in silico characterization and clinical validation | PDF",1790094036,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1942b8b04c825dd1650182cb1f1777b3.webp",983,1310,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6834ed7e53b66417635e2e529051206a.webp",982,1309,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/981df25dad2c43c5ff2f64a4bfde369d.webp",981,1308,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a9d0c385e364587b275aab78ac660941.webp",980,1306]